Associations Between Microstructure, Amyloid, and Cognition in Amnestic Mild Cognitive Impairment and Dementia.

Published on Jan 1, 2020in Journal of Alzheimer's Disease3.909
· DOI :10.3233/JAD-190871
Emilie T. Reas13
Estimated H-index: 13
(UCSD: University of California, San Diego),
Donald J. Hagler88
Estimated H-index: 88
(UCSD: University of California, San Diego)
+ 7 AuthorsJames B. Brewer50
Estimated H-index: 50
(UCSD: University of California, San Diego)
Sources
Abstract
BACKGROUND: Although amyloid-beta (Abeta) and microstructural brain changes are both effective biomarkers of Alzheimer's disease, their independent or synergistic effects on cognitive decline are unclear. OBJECTIVE: To examine associations of Abeta and brain microstructure with cognitive decline in amnestic mild cognitive impairment and dementia. METHODS: Restriction spectrum imaging, cerebrospinal fluid Abeta, and longitudinal cognitive data were collected on 23 healthy controls and 13 individuals with mild cognitive impairment or mild to moderate Alzheimer's disease. Neurite density (ND) and isotropic free water diffusion (IF) were computed in fiber tracts and cortical regions of interest. We examined associations of Abeta with regional and whole-brain microstructure, and assessed whether microstructure mediates effects of Abeta on cognitive decline. RESULTS: Lower ND in limbic and association fibers and higher medial temporal lobe IF predicted baseline impairment and longitudinal decline across multiple cognitive domains. ND and IF predicted cognitive outcomes after adjustment for Abeta or whole-brain microstructure. Correlations between microstructure and cognition were present for both amyloid-positive and amyloid-negative individuals. Abeta correlated with whole-brain, rather than regional, ND and IF. CONCLUSION: Abeta correlates with widespread microstructural brain changes, whereas regional microstructure correlates with cognitive decline. Microstructural abnormalities predict cognitive decline regardless of amyloid, and may inform about neural injury leading to cognitive decline beyond that attributable to amyloid.
📖 Papers frequently viewed together
9 Authors (Fang Ji, ..., Juan Zhou)
References46
Newest
#1Darren Weber (Quest Diagnostics)H-Index: 8
#1Darren Weber (Quest Diagnostics)H-Index: 1
Last. Nigel J. Clarke (Quest Diagnostics)H-Index: 26
view all 9 authors...
Background: The ratio of β-amyloid 1–42 (Aβ42) to Aβ40 in cerebrospinal fluid (CSF) may be useful for evaluating Alzheimer disease (AD), but quantification is limited by factors including preanalytical analyte loss. We developed an LC-MS/MS assay that limits analyte loss. Here we describe the analytical characteristics of the assay and its performance in differentiating patients with AD from non-AD dementia and healthy controls. Methods: To measure Aβ42/Aβ40, we used unique proteolytically deriv...
5 CitationsSource
#1Kevin McRae-McKee (Imperial College London)H-Index: 5
#2Chinedu T. Udeh-Momoh (Imperial College London)H-Index: 7
view all 14 authors...
Abstract The 2018 National Institute on Aging and the Alzheimer's Association (NIA-AA) research framework recently redefined Alzheimer's disease (AD) as a biological construct, based on in vivo biomarkers reflecting key neuropathologic features. Combinations of normal/abnormal levels of three biomarker categories, based on single thresholds, form the AD signature profile that defines the biological disease state as a continuum, independent of clinical symptomatology. While single thresholds may ...
9 CitationsSource
#1Seong Jae Hwang (UW: University of Wisconsin-Madison)H-Index: 4
#2Nagesh Adluru (UW: University of Wisconsin-Madison)H-Index: 25
Last. Vikas Singh (UW: University of Wisconsin-Madison)H-Index: 27
view all 6 authors...
Abstract Characterizing Alzheimer's disease (AD) at pre-clinical stages is crucial for initiating early treatment strategies. It is widely accepted that amyloid accumulation is a primary pathologic...
5 CitationsSource
#1Jennifer S. Rabin (Harvard University)H-Index: 17
#2Rodrigo D. Perea (Harvard University)H-Index: 9
Last. Trey Hedden (Harvard University)H-Index: 6
view all 8 authors...
: White matter degradation has been proposed as one possible explanation for age-related cognitive decline. In the present study, we examined 2 main questions: 1) Do diffusion characteristics predict longitudinal change in cognition independently or synergistically with amyloid status? 2) Are the effects of diffusion characteristics on longitudinal cognitive change tract-specific or global in nature? Cognitive domains of executive function, episodic memory, and processing speed were measured ann...
24 CitationsSource
#1Xin Zhang (NU: Nanjing University)H-Index: 34
#1Xin Zhang (NU: Nanjing University)H-Index: 62
Last. Bing Zhang (NU: Nanjing University)H-Index: 126
view all 16 authors...
Abstract Brain white matter fiber bundles in patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD) have abnormalities not usually seen in unaffected subjects. Ideal algorithm of the localization-specific properties in white matter integrity might reveal the changes of tissue properties varying along each tract, while previous studies only detected the mean DTI parameters of each fiber. The aim of this study was to investigate whether these abnormalities of nerve fiber tracts...
12 CitationsSource
#1Jorge Sepulcre (Harvard University)H-Index: 49
#2Michel J. Grothe (German Center for Neurodegenerative Diseases)H-Index: 33
Last. Keith A. Johnson (Harvard University)H-Index: 134
view all 12 authors...
Tau and amyloid beta (Aβ) proteins accumulate along neuronal circuits in Alzheimer’s disease. Unraveling the genetic background for the regional vulnerability of these proteinopathies can help in understanding the mechanisms of pathology progression. To that end, we developed a novel graph theory approach and used it to investigate the intersection of longitudinal Aβ and tau positron emission tomography imaging of healthy adult individuals and the genetic transcriptome of the Allen Human Brain A...
58 CitationsSource
#1Stephanie L. Leal (HWNI: Helen Wills Neuroscience Institute)H-Index: 14
#2Samuel N. Lockhart (Wake Forest University)H-Index: 21
Last. William J. Jagust (HWNI: Helen Wills Neuroscience Institute)H-Index: 140
view all 5 authors...
Current approaches to the early detection of Alzheimer9s disease (AD) rely upon classifying individuals as “positive” or “negative” for biomarkers related to the core pathology of beta-amyloid (Aβ). However, the accumulation of Aβ begins slowly, years before biomarkers become abnormal. We used longitudinal [ 11 C] Pittsburgh Compound B (PIB) PET and neuropsychological assessment to investigate the earliest changes in AD pathology and how it affects memory in cognitively normal older humans (N = ...
60 CitationsSource
#1Emilie T. Reas (UCSD: University of California, San Diego)H-Index: 13
#2Donald J. Hagler (UCSD: University of California, San Diego)H-Index: 88
Last. Linda K. McEvoy (UCSD: University of California, San Diego)H-Index: 66
view all 10 authors...
Abstract Improved characterization of the microstructural brain changes occurring in the early stages of Alzheimer's disease may permit more timely disease detection. This study examined how longitudinal change in brain microstructure relates to cognitive decline in aging and prodromal Alzheimer's disease. At baseline and two-year follow-up, 29 healthy controls and 21 individuals with mild cognitive impairment or mild Alzheimer's disease underwent neuropsychological evaluation and restriction sp...
8 CitationsSource
#1Emilie T. Reas (UCSD: University of California, San Diego)H-Index: 13
#2Donald J. Hagler (UCSD: University of California, San Diego)H-Index: 88
Last. Linda K. McEvoy (UCSD: University of California, San Diego)H-Index: 66
view all 14 authors...
Background Diffusion imaging has demonstrated sensitivity to structural brain changes in Alzheimer’s disease (AD). However, there remains a need for a more complete characterization of microstructural alterations occurring at the earliest disease stages, and how these changes relate to underlying neuropathology. This study evaluated the sensitivity of restriction spectrum imaging (RSI), an advanced diffusion magnetic resonance imaging (MRI) technique, to microstructural brain changes in mild cog...
10 CitationsSource
#1Kejal Kantarci (Mayo Clinic)H-Index: 75
#2Melissa E. Murray (Mayo Clinic)H-Index: 64
Last. Dennis W. Dickson (Mayo Clinic)H-Index: 216
view all 16 authors...
Pattern of diffusion tensor MRI (DTI) alterations were investigated in pathologically-staged Alzheimer's disease (AD) patients (n = 46). Patients with antemortem DTI studies and a range of AD pathology at autopsy were included. Patients with a high neurofibrillary tangle (NFT) stage (Braak IV–VI) had significantly elevated mean diffusivity (MD) in the crus of fornix and ventral cingulum tracts, precuneus, and entorhinal white matter on voxel-based analysis after adjusting for age and time from M...
73 CitationsSource
Cited By1
Newest
There has been an increasing prevalence of neurodegenerative diseases with the rapid increase in aging societies worldwide. Biomarkers that can be used to detect pathological changes before the development of severe neuronal loss and consequently facilitate early intervention with disease-modifying therapeutic modalities are therefore urgently needed. Diffusion magnetic resonance imaging (MRI) is a promising tool that can be used to infer microstructural characteristics of the brain, such as mic...
Source
#1Sheelakumari Raghavan (Mayo Clinic)
#2Robert I. Reid (Mayo Clinic)H-Index: 20
Last. Prashanthi Vemuri (Mayo Clinic)H-Index: 74
view all 12 authors...
Source
#1Emilie T. Reas (UCSD: University of California, San Diego)H-Index: 13
#2Donald J. Hagler (UCSD: University of California, San Diego)H-Index: 88
Last. Linda K. McEvoy (UCSD: University of California, San Diego)H-Index: 66
view all 6 authors...
Abstract Cytoarchitectural brain changes within gray matter and fiber tracts during normal aging remain poorly characterized, and it is unclear whether rates and patterns of brain aging differ by sex. This study used restriction spectrum imaging (RSI) to examine associations between age and brain microstructure in 147 community-dwelling participants (aged 56-99). Widespread associations with older age in multiple diffusion compartments, including increased free water, decreased restricted and hi...
1 CitationsSource